Factors associated with Medicaid patients' access to buprenorphine treatment
Name:
Publisher version
View Source
Access full-text PDFOpen Access
View Source
Check access options
Check access options
Student Authors
Yat (Gary) LeungUMass Chan Affiliations
Center for Health Policy and ResearchDepartment of Family Medicine and Community Health
Document Type
Journal ArticlePublication Date
2011-07-01Keywords
Opioid-Related Disorders; Opiate Substitution Treatment; Buprenorphine; MedicaidHealth Services Research
Life Sciences
Medicine and Health Sciences
Public Health
Substance Abuse and Addiction
Metadata
Show full item recordAbstract
Some studies have shown that patients entering buprenorphine treatment differ from those in other modalities. This study compares Massachusetts Medicaid beneficiaries who received buprenorphine, methadone or other treatment for opioid addiction in 2007. Patients' characteristics and comorbidities were identified through claims data, and associations between these factors and treatment type were investigated using multivariate analysis. Among patients receiving opioid agonist treatments, patients with prior buprenorphine treatment, HIV, bipolar disease, and other substance use disorders were more likely to receive buprenorphine treatment compared with methadone, whereas patients with heart failure, diabetes, hepatitis C, major depression, and anxiety were less likely to receive buprenorphine treatment. These differences may suggest variability in patient access, treatment preferences, and a need for different levels of services in different modalities. This information is important for understanding the impact of this new treatment in Medicaid populations and for developing treatment systems to best meet patients' needs.Source
J Subst Abuse Treat. 2011 Jul;41(1):88-96. Epub 2011 Apr 2. Link to article on publisher's websiteDOI
10.1016/j.jsat.2011.02.002Permanent Link to this Item
http://hdl.handle.net/20.500.14038/33209PubMed ID
21459544Related Resources
Link to article in PubMedae974a485f413a2113503eed53cd6c53
10.1016/j.jsat.2011.02.002